The Time Is Now
Find out why physicians are excited about bringing BT to patients with severe asthmaWatch Video
Identifying BT Candidates
Who is BT for?
BT is for patients with severe asthma ≥ 18 years old who are on inhaled corticosteroids and long-acting beta2 agonists but still experience asthma symptoms and/or risk of future exacerbations.
These can include patients with any one of the following:
- Asthma exacerbations requiring oral corticosteroids
- ER, urgent care, or unscheduled office visits in the past 12 months
- Use of rescue inhaler > 2x per week
- Physical or activity limitations due to asthma
BT has 5 years of effectiveness and safety data
Learn more about the 5 year clinical safety data that demonstrate benefits of BT are maintained long term.
Click on the individual trial name, below, for additional information on each clinical study.
|AIR2 5 Year
|AIR2 Trial||RISA Trial|
Treatment With BT
BT is delivered by the Alair™ System in 3 short sessions, using a device called the Alair™ Catheter. No incisions or full anesthesia necessary. Sessions are typically scheduled 3 weeks apart. Each session is routinely performed under moderate sedation and typically takes less than an hour to complete.